Learn more about the world’s first UVC germ-fighting robot.
When we were first awarded patents for Tru-D, we envisioned a seamlessly connected hospital staff. Now, from the time daytime staff completes daily room disinfection routines to the time surgical services staff begins the night shift, the day’s infection control data is accessible with the click of a button.
The pioneer in the UVC disinfection industry, Tru-D was introduced to the health care industry in 2007 and continues to be the gold standard in the space. Tru-D is the only device with intuitive Sensor360 technology that accurately calculates the precise dose of UVC light needed to kill up to 99.9% of harmful pathogens. Operating from a single position and administering a single cycle of UV energy, Tru-D provides total room disinfection, including in shadowed areas.
While Tru-D has been on the market for more than a decade, the technology behind Tru-D has a much richer history. Originally sold under Lumalier – a company with a 50-year history in the UV germicidal industry – multiple patents and more than a decade of research and clinical trials were obtained on Tru-D.
Today, Tru-D continues to be the device of choice for nearly all of the existing independent research on UV disinfection technology including the first-ever randomized clinical trial on UV disinfection. Tru-D was the sole device chosen for the $2 million study funded by the Centers for Disease Control’s Prevention Epicenter Program at Duke University, the University of North Carolina and seven other hospitals in the region. Results showed that enhanced terminal room disinfection strategies using Tru-D decreased the relative risk of colonization or infection from target MDROs among patients admitted to the same room by a cumulative 30 percent when standard disinfection protocols were followed 93 percent of the time. Individual hospital results may vary.
Tru-D’s effectiveness and accuracy have been supported by a number of other independent, peer-reviewed studies conducted by leading authorities in infection control and epidemiology. Third-party, peer-reviewed research using Tru-D includes published studies on Clostridium difficile (C. diff), Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE).
Bearing the marks of both Intertek and ETL safety ratings, Tru-D is a chemical-free, environmentally-friendly addition to any hospital’s EVS team. Tru-D’s bulbs are safe, energy efficient and are made the same way compact fluorescent bulbs already being used hospital-wide are made.
More Tru-D’s have been deployed throughout the U.S. than any of its lookalike offerings and is currently eliminating germs in hospitals in the U.S., Canada and Europe, including the National Institutes of Health, Lehigh Valley Health Network, Walter Reed Army Medical Center, Houston Methodist, University of Pittsburgh Medical Center, many VA medical centers and Nottingham University Hospitals NHS Trust.
Oftentimes, hospitals refer to their robot as “Trudi,” as she becomes an integral member of the EVS team.
To read more about Tru-D’s technology, click here or to have a Tru-D representative contact you, please e-mail us at firstname.lastname@example.org.